Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02996227 · ClinicalTrials.gov registry record · NA
Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 514
- Enrollment target
NCT02996227 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 514 participants.
The verdict
NCT02996227, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 514 participants
- Enrollment target
Study Summary
Comparison of Bilateral Transversus Abdominis Plane Block with Exparel versus Continuous Epidural Analgesia With Bupivacaine
Interventions
- DRUG Bupivacaine
- DRUG EXPAREL
- PROCEDURE TAP block
- PROCEDURE Epidural analgesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 514 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02996227
The ClinicalTrials.gov registry entry for NCT02996227 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 514 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Bupivacaine is the first listed.
NCT02996227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02996227 about?
NCT02996227 is a clinical study titled "Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine". Comparison of Bilateral Transversus Abdominis Plane Block with Exparel versus Continuous Epidural Analgesia With Bupivacaine
What is the current status of trial NCT02996227?
This trial is currently completed. It is a NA study. The enrollment target is 514 participants. The study started on 2016-12. Estimated completion is 2019-10.
What interventions are being tested in trial NCT02996227?
The interventions under investigation include: Bupivacaine (DRUG), EXPAREL (DRUG), TAP block (PROCEDURE), Epidural analgesia (PROCEDURE).
Who is sponsoring clinical trial NCT02996227?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.